Hepatitis C virus (HCV) protease NS3 and its protein activator NS4A pa
rticipate in the processing of the viral polyprotein into its constitu
ent nonstructural proteins. The NS3/4A complex is thus an attractive t
arget for antiviral therapy against HCV. We expressed the full-length
NS3 and NS4A in insect cells as a soluble fusion protein with an N-ter
minal polyhistidine tag and purified the two proteins to homogeneity.
Cleavage at the junction between HisNS3 and NS4A occurs during express
ion, producing a noncovalent complex between HisNS3 and NS4A with a su
bnanomolar dissociation constant. We purified the HisNS3/4A complex by
detergent extraction of cell lysate and by metal chelate chromatograp
hy. We removed the His tag by thrombin cleavage and then further purif
ied the complex by gel filtration. The purified NS3/4A complex is acti
ve in a protease assay using a synthetic peptide substrate derived fro
m the NS5A-NS5B junction, with k(cat)/K-m of 3700 (+/- 600) M-1 s(-1),
an order of magnitude above those previously reported for NS3 express
ed by other strategies. This high protease activity implies that the f
ull-length sequences of NS3 and NS4A are required for optimal activity
of the NS3 protease domain. We examined the dependence of the NS3/4A
protease activity on buffer conditions, temperature, and the presence
of detergents. We find that, under most conditions, NS3 protease activ
ity is dependent on the aggregation state of the NS3/4A complex. The m
onodisperse, soluble form of the NS3/4A complex is associated with the
highest protease activity.